These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11419656)

  • 1. Light and electron microscopic analyses for ischaemia-reperfusion lung injury in an ovine cardiopulmonary bypass model.
    Kim WG; Lee BH; Seo JW
    Perfusion; 2001 May; 16(3):207-14. PubMed ID: 11419656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parameters of pulmonary injury after total or partial cardiopulmonary bypass.
    Friedman M; Sellke FW; Wang SY; Weintraub RM; Johnson RG
    Circulation; 1994 Nov; 90(5 Pt 2):II262-8. PubMed ID: 7955263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled lung reperfusion to reduce pulmonary ischaemia/reperfusion injury after cardiopulmonary bypass in a porcine model.
    Slottosch I; Liakopoulos O; Kuhn E; Deppe A; Lopez-Pastorini A; Schwarz D; Neef K; Choi YH; Sterner-Kock A; Jung K; Mühlfeld C; Wahlers T
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):962-70. PubMed ID: 25142069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane oxygenator prevents lung reperfusion injury in canine cardiopulmonary bypass.
    Gu YJ; Wang YS; Chiang BY; Gao XD; Ye CX; Wildevuur CR
    Ann Thorac Surg; 1991 Apr; 51(4):573-8. PubMed ID: 2012415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine reduces lung reperfusion injury after deep hypothermia and total circulatory arrest.
    Cakir O; Oruc A; Kaya S; Eren N; Yildiz F; Erdinc L
    J Card Surg; 2004; 19(3):221-5. PubMed ID: 15151648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of cardiopulmonary bypass decreases leukocyte count and activation of the complement system].
    Bochenek A; Religa Z; Kokot F; Knapik P; Wnuk R; Komarski K; Wojnar J; Pietrzycki A; Skiba J
    Kardiol Pol; 1992; 36(2):67-72. PubMed ID: 1583828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does sodium nitroprusside reduce lung injury under cardiopulmonary bypass?
    Cakir O; Oruc A; Eren S; Buyukbayram H; Erdinc L; Eren N
    Eur J Cardiothorac Surg; 2003 Jun; 23(6):1040-5. PubMed ID: 12829085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural changes in the lung alveoli after cardiac surgical operations with the use of cardiopulmonary bypass (CPB).
    Wasowicz M; Sobczyński P; Biczysko W; Szulc R
    Pol J Pathol; 1999; 50(3):189-96. PubMed ID: 10624121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does aprotinin reduce lung reperfusion damage after cardiopulmonary bypass?
    Rahman A; Ustünda B; Burma O; Ozercan IH; Cekirdekçi A; Bayar MK
    Eur J Cardiothorac Surg; 2000 Nov; 18(5):583-8. PubMed ID: 11053821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pressure drop, shear stress, and activation of leukocytes during cardiopulmonary bypass: a comparison between hollow fiber and flat sheet membrane oxygenators.
    Gu YJ; Boonstra PW; Graaff R; Rijnsburger AA; Mungroop H; van Oeveren W
    Artif Organs; 2000 Jan; 24(1):43-8. PubMed ID: 10677156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of dextran sulfate to blood cardioplegia attenuates reperfusion injury in a porcine model of cardiopulmonary bypass.
    Banz Y; Rieben R; Zobrist C; Meier P; Shaw S; Lanz J; Carrel T; Berdat P
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):653-60. PubMed ID: 18572413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators.
    Cavarocchi NC; Pluth JR; Schaff HV; Orszulak TA; Homburger HA; Solis E; Kaye MP; Clancy MS; Kolff J; Deeb GM
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):252-8. PubMed ID: 3511328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental study in a rabbit model of ischemia-reperfusion lung injury during cardiopulmonary bypass.
    Kuratani T; Matsuda H; Sawa Y; Kaneko M; Nakano S; Kawashima Y
    J Thorac Cardiovasc Surg; 1992 Mar; 103(3):564-8. PubMed ID: 1545556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary injury after total or partial cardiopulmonary bypass with thromboxane synthesis inhibition.
    Friedman M; Wang SY; Sellke FW; Franklin A; Weintraub RM; Johnson RG
    Ann Thorac Surg; 1995 Mar; 59(3):598-603. PubMed ID: 7887696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel anti-factor D monoclonal antibody inhibits complement and leukocyte activation in a baboon model of cardiopulmonary bypass.
    Undar A; Eichstaedt HC; Clubb FJ; Fung M; Lu M; Bigley JE; Vaughn WK; Fraser CD
    Ann Thorac Surg; 2002 Aug; 74(2):355-62; discussion 362. PubMed ID: 12173813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose dopexamine's effect on lung and gut function after CPB in a sheep model.
    Stamler A; Wang H; Weintraub RM; Hariawala MD; Fink MP; Johnson RG
    J Surg Res; 1998 Feb; 74(2):165-72. PubMed ID: 9587356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase inhibitor: differential effects on pulmonary neutrophil and monocyte sequestration following cardiopulmonary bypass.
    McCann UG; Gatto LA; Searles B; Carney DE; Lutz CJ; Picone AL; Schiller HJ; Nieman GF
    J Extra Corpor Technol; 1999 Jun; 31(2):67-75. PubMed ID: 10724645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase type 4 inhibitor prevents acute lung injury induced by cardiopulmonary bypass in a rat model.
    Hamamoto M; Suga M; Nakatani T; Takahashi Y; Sato Y; Inamori S; Yagihara T; Kitamura S
    Eur J Cardiothorac Surg; 2004 May; 25(5):833-8. PubMed ID: 15082290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rat model of cardiopulmonary bypass with cardioplegic arrest and hemodynamic assessment by conductance catheter technique.
    Günzinger R; Wildhirt SM; Schad H; Heimisch W; Gurdan M; Mendler N; Grammer J; Lange R; Bauernschmitt R
    Basic Res Cardiol; 2007 Nov; 102(6):508-17. PubMed ID: 17668258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activation of complement and serial changes of anaphylatoxin (C3a, C5a) in patients for open-heart surgery using a membrane oxygenator].
    Mitsuhata H; Enzan K; Hasegawa J; Matumoto S; Matsumoto J; Kurosawa S
    Masui; 1992 Feb; 41(2):194-9. PubMed ID: 1552659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.